Johnson and Johnson is making an offer to acquire all the shares it doesn’t already own of Crucell NV for about €1.75 billion or at €24.75 per share. J&J currently owns 17.9% of Crucell. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
